Maralee Rachel Kanin

Maralee Kanin practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Maralee Kanin's NPI, 1467984260, was assigned on March 30, 2017. Maralee Kanin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2017. Maralee Kanin holds California license A160394.

Maralee Kanin's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Maralee Kanin's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Maralee Kanin is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Maralee Kanin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Maralee Kanin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Maralee Kanin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Maralee Kanin is board certified in endocrinology and metabolism by the American Board of Internal Medicine. Maralee Kanin is licensed in California.

CMS data shows 102 Medicare services from Maralee Kanin across 4 procedure codes in 2024, for 96 Medicare patients. Medicare paid $11,582 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Maralee Kanin in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maralee Kanin's median patient age at 51, with 68% women.

In 2024, Maralee Kanin wrote 134 Medicare Part D claims for 49 patients. 53% of them were for generic drugs. CMS names the drug for 49 of them, across 2 drugs with 11 or more claims each, at $509 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Maralee Kanin for performance year 2024, reported as part of a group. Maralee Kanin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Maralee Kanin as offering telehealth.

CMS Open Payments shows 2 general payments to Maralee Kanin from 2 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $112.

Maralee Kanin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2017.

Maralee Kanin is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Regence Health Plans. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.